Drug profile · INN
trimethobenzamide hydrochloride
TRIMETHOBENZAMIDE HYDROCHLORIDE
trimethobenzamide hydrochloride (TRIMETHOBENZAMIDE HYDROCHLORIDE) is a unknown. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — trimethobenzamide hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
trimethobenzamide hydrochloride (TRIMETHOBENZAMIDE HYDROCHLORIDE) is a unknown. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is trimethobenzamide hydrochloride?
trimethobenzamide hydrochloride (TRIMETHOBENZAMIDE HYDROCHLORIDE) is a unknown. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for trimethobenzamide hydrochloride?
TRIMETHOBENZAMIDE HYDROCHLORIDE is a marketed brand name for trimethobenzamide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trimethobenzamide hydrochloride?
trimethobenzamide hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.